Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Glympse Bio
Biotech
Former FDA leader joins YourBio as interim CMO—Chutes & Ladders
Former FDA Commissioner Hahn joins YourBio as interim CMO. Gilead's liver diseases leader leaves for Glympse Bio. Orchard picks up CTO, CSO and CMO.
Kyle LaHucik
Sep 10, 2021 9:30am
Glympse Bio names Gilead vet as first chief medical officer
Sep 8, 2021 2:57pm
Glympse Bio clears first-in-human study of injectable biosensors
Nov 16, 2020 10:49am
Glympse Bio nets $46M to boost its injectable NASH diagnostics
Jul 15, 2020 10:25am
Gilead taps Glympse Bio for its synthetic NASH biomarkers
Oct 28, 2019 11:34am
AstraZeneca nets exec to lead breast cancer R&D—Chutes & Ladders
May 17, 2019 9:00am